Is science stuck in the middle ages?

July 31, 2003

This week's editorial discusses some of the problems that biomedical scientists face in their career paths as the structure of research is changing from small-scale investigator-led research to large-scale "discovery science", such as the Human Genome Project. Discussing a recent book by the US National Academies, the editorial comments that scientific training will have to move away from the apprentice model used world-wide to something that equips scientists better for these projects, for example with more management training. In addition the editorial says, "scientists who choose to become managers will have to have their careers recognised as valid, not just by remuneration, but also by their peers. Thus traditional ways of training and assessing scientists -- peer-reviewed publications, and ability to attract independent funding -- will have to be rethought."

This rethinking of scientific training is particularly important as innovation in biomedical research is being avoided by pharmaceutical companies, who are becoming more averse to risk. As the editorial says "Whereas previously pharmaceutical companies took on the risk of investigating potential drugs, now it is more likely to be small biotech companies, often spin-offs from universities doing the underlying basic research, which do so." The editorial notes however that this interface can pose problems with potential conflicts of interest for scientist and universities.


Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to